登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，3月7日，COVID-19: too little, too late?》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-06

  • COVID-19: too little, too late?

    The Lancet

    Published:March 07, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30522-5

    Although WHO has yet to call the outbreak of SARS-CoV-2 infection a pandemic, it has confirmed that the virus is likely to spread to most, if not all, countries. Regardless of terminology, this latest coronavirus epidemic is now seeing larger increases in cases outside China. As of March 3, more than 90 000 confirmed cases of COVID-19 have been reported in 73 countries.

  • 原文来源：https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30522-5/fulltext
12浏览量
原文链接
相关报告

  • 《LANCET，3月23日，COVID-19 and medical education》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-24
    • COVID-19 and medical education Hanad Ahmed Mohammed Allaf Hussein Elghazaly Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30226-7 The coronavirus disease 2019 (COVID-19) outbreak has rapidly transitioned into a worldwide pandemic. This development has had serious implications for public institutions and raises particular questions for medical schools. Frequent rotations between departments and hospitals make medical students potential vectors for COVID-19. Equally, as trainee doctors we stand to learn a tremendous amount and can contribute to the care of patients, particularly if the UK General Medical Council triggers article 18a of the Medical Student Act (1983).
    124浏览量
    原文链接

  • 《LANCET，3月20日，COVID-19 and the liver: little cause for concern》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-21
    • COVID-19 and the liver: little cause for concern Mansoor N Bangash Jaimin Patel Dhruv Parekh Published:March 20, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30084-4 The largest study on COVID-19 to date1 showed that the prevalence of elevated aminotransferases and bilirubin in people faring worst was at least double that of others. Although clinically significant liver dysfunction was not quantified, this and other studies have led some to suggest that this finding might present clinical challenges.2 Close inspection of the available data supports a higher prevalence of abnormal aminotransferase levels in severe COVID-19 disease, but these studies actually suggest that clinically significant liver injury is uncommon, even when data for the most severely ill patients are selected (table).
    110浏览量
    原文链接